REED ELIZABETH E (SVP, GC & Corporate Secretary) sold 32.9% of their position (51.50K shares) of TRAVERE THERAPEUTICS, INC. on the open market

Open‑market sale worth $2.13M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales

REED ELIZABETH E

Filed: 4/16/2026ACC: 0001283303-26-000008

InsiderREED ELIZABETH ECIK 1283303

→

IssuerTRAVERE THERAPEUTICS, INC.CIK 1438533

Officer· SVP, GC & Corporate Secretary

Since Nov 2018

-37.50K

Net shares

Net seller

$2.13M

Total sold

Open market trades

0B · 4S

Total transactions

51.50K acquired · 89K disposed

Non-Derivative Transactions8

Common Stock

Direct

A · Award

+14K

Price / share

—

Trade value

—

% of position

13.3%

4/13/2026

105.21K→119.21K

Common Stock

Direct

M · Option Exercise

+10K

Price / share

$19.08

Trade value

$190.80K

% of position

8.4%

4/14/2026

119.21K→129.21K

Common Stock

Direct

M · Option Exercise

+20K

Price / share

$17.96

Trade value

$359.20K

% of position

15.5%

4/14/2026

129.21K→149.21K

Common Stock

Direct

M · Option Exercise

+7.50K

Price / share

$15.46

Trade value

$115.95K

% of position

5.0%

4/14/2026

149.21K→156.71K

Common Stock

Direct

S · Sale

−37.50K

Price / share

$41.07

Trade value

$1.54M

% of position

23.9%

4/14/2026

156.71K→119.21K

Common Stock

Direct

S · Sale

−7.21K

Price / share

$41.93

Trade value

$302.52K

% of position

6.1%

4/14/2026

119.21K→112K

Common Stock

Direct

S · Sale

−5.23K

Price / share

$41.62

Trade value

$217.51K

% of position

4.7%

4/15/2026

112K→106.77K

Common Stock

Direct

S · Sale

−1.56K

Price / share

$42.53

Trade value

$66.30K

% of position

1.5%

4/15/2026

106.77K→105.21K

Total

Net shares

+0.00

Net value

-$1.46M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	4/13/2026	A · Award	+14K	—	—	13.3%	105.21K	119.21K
Common Stock Direct	4/14/2026	M · Option Exercise	+10K	$19.08	$190.80K	8.4%	119.21K	129.21K
Common Stock Direct	4/14/2026	M · Option Exercise	+20K	$17.96	$359.20K	15.5%	129.21K	149.21K
Common Stock Direct	4/14/2026	M · Option Exercise	+7.50K	$15.46	$115.95K	5.0%	149.21K	156.71K
Common Stock Direct	4/14/2026	S · Sale	−37.50K	$41.07	$1.54M	23.9%	156.71K	119.21K
Common Stock Direct	4/14/2026	S · Sale	−7.21K	$41.93	$302.52K	6.1%	119.21K	112K
Common Stock Direct	4/15/2026	S · Sale	−5.23K	$41.62	$217.51K	4.7%	112K	106.77K
Common Stock Direct	4/15/2026	S · Sale	−1.56K	$42.53	$66.30K	1.5%	106.77K	105.21K
Total			+0.00		-$1.46M

Derivative Transactions3

Employee stock option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

7.50K shares

−7.50K

Strike price

15.46

Held after

37.50K

Exercisable

—

4/14/2026

Employee stock option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

10K shares

−10K

Strike price

19.08

Held after

0.00

Exercisable

—

4/14/2026

Employee stock option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

20K shares

−20K

Strike price

17.96

Held after

20K

Exercisable

—

4/14/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Employee stock option (right to buy) Direct	Common Stock7.50K shares	4/14/2026	M · Option Exercise	−7.50K	15.46	—	37.50K
Employee stock option (right to buy) Direct	Common Stock10K shares	4/14/2026	M · Option Exercise	−10K	19.08	—	0.00
Employee stock option (right to buy) Direct	Common Stock20K shares	4/14/2026	M · Option Exercise	−20K	17.96	—	20K